UAB Digital Repository of Documents 2 records found  Search took 0.01 seconds. 
12 p, 1.2 MB The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain / Azanza, José Ramón (Clínica Universidad de Navarra) ; Grau, Santiago (Hospital del Mar (Barcelona, Catalunya)) ; Vázquez, Lourdes (Hospital Clínico Universitario (Salamanca)) ; Rebollo, Pablo (Ingress-health) ; Peral, Carmen (Pfizer) ; López-Ibáñez de Aldecoa, Alejandra (Pfizer) ; López-Gómez, Vanessa (Pfizer) ; Universitat Autònoma de Barcelona
Invasive mould diseases are associated with high morbidity, mortality and economic impact. Its treatment is often started prior to differential pathogen diagnosis. Isavuconazole is approved for treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM) when amphotericin-B is not indicated. [...]
2020 - 10.1111/myc.13189
Mycoses, Vol. 64 (october 2020) , p. 66-77  
17 p, 1.1 MB Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy : a position paper / Los Arcos, Ibai (Hospital Universitari Vall d'Hebron) ; Iacoboni, Gloria (Vall d'Hebron Institut d'Oncologia) ; Aguilar-Guisado, Manuela (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Alsina Manrique, Laia (Hospital Sant Joan de Déu) ; Díaz de Heredia, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fortuny Guasch, Claudia (Hospital Sant Joan de Déu) ; García Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ; García Vidal, Carolina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; González Vicent, Marta (Hospital Infantil Universitario Niño Jesús) ; Hernani, Rafael (Hospital Clínic Universitari (València)) ; Kwon, Mi (Hospital General Universitario Gregorio Marañón) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Martínez Gómez, Xavier (Hospital Universitari Vall d'Hebron) ; Ortiz Maldonado, Valentín (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Pinto Pla, Carolina (Hospital Clínic Universitari (València)) ; Piñana, José Luis (Hospital Universitari i Politècnic La Fe (València)) ; Pomar, Virginia (Institut d'Investigació Biomèdica Sant Pau) ; Reguera Ortega, Juan Luis (Hospital Universitari i Politècnic La Fe (València)) ; Salavert, Miguel (Hospital Universitari i Politècnic La Fe (València)) ; Soler-Palacín, Pere (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vázquez López, Lourdes (Hospital Universitario de Salamanca) ; Barba, Pere (Universitat Autònoma de Barcelona. Departament de Medicina) ; Ruiz Camps, Isabel (Universitat Autònoma de Barcelona. Departament de Medicina)
Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising emerging treatments for B-cell malignancies. Recently, two CAR T-cell products (axicabtagene ciloleucel and tisagenlecleucel) have been approved for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia; many other CAR-T constructs are in research for both hematological and non-hematological diseases. [...]
2020 - 10.1007/s15010-020-01521-5
Infection, september 2020, p. 1-17  

See also: similar author names
1 Vázquez, L.
1 Vázquez, Liliana
1 Vázquez, Luci
2 Vázquez, Luis
1 Vázquez, Luis Alberto
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.